Zydus Lifesciences climbs on planning to launch Semaglutide injection in India
Mumbai, February 26 (Udaipur Kiran): Zydus Lifesciences is currently trading at Rs. 941.50, up by 22.10 points or 2.40% from its previous closing of Rs. 919.40 on the BSE. The scrip opened at Rs. 937.90 and has touched a high and low of Rs. 947.70 and Rs. 922.20 respectively. So far 21972 shares were traded … Read more
